Genertec Universal Medical Group Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Wang Wenbing
Chief executive officer
CN¥4.3m
Total compensation
| CEO salary percentage | 33.4% |
| CEO tenure | 7.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4.4yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E
Feb 05
Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34
Jun 08Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 08Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 31Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?
Aug 20Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching
Apr 19Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return
Mar 10Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?
Feb 19Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?
Feb 01
The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?
Jan 11What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?
Dec 21Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years
Nov 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | CN¥2b |
| Sep 30 2023 | n/a | n/a | CN¥2b |
| Jun 30 2023 | n/a | n/a | CN¥2b |
| Mar 31 2023 | n/a | n/a | CN¥2b |
| Dec 31 2022 | CN¥4m | CN¥1m | CN¥2b |
| Sep 30 2022 | n/a | n/a | CN¥2b |
| Jun 30 2022 | n/a | n/a | CN¥2b |
| Mar 31 2022 | n/a | n/a | CN¥2b |
| Dec 31 2021 | CN¥2m | CN¥731k | CN¥2b |
Compensation vs Market: Wang's total compensation ($USD598.67K) is about average for companies of similar size in the Hong Kong market ($USD485.88K).
Compensation vs Earnings: Wang's compensation has increased by more than 20% in the past year.
CEO
Wang Wenbing (49 yo)
7.3yrs
Tenure
CN¥4,335,000
Compensation
Mr. Wang Wenbing is General Manager of China Universal Leasing Co., Ltd since October 14, 2021. He has been Deputy General Manager of Genertec Universal Medical Group Company Limited (formerly known as Uni...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairwoman | 9.4yrs | CN¥4.66m | 0.40% CN¥ 36.0m | |
| CEO & Executive Director | 7.3yrs | CN¥4.34m | no data | |
| Chief Accountant | no data | no data | no data | |
| Chief Medical Officer | no data | no data | no data | |
| Executive Director | less than a year | no data | no data | |
| Company Secretary | 4.4yrs | no data | no data |
4.4yrs
Average Tenure
49yo
Average Age
Experienced Management: 2666's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairwoman | 9.4yrs | CN¥4.66m | 0.40% CN¥ 36.0m | |
| CEO & Executive Director | 2.7yrs | CN¥4.34m | no data | |
| Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 8.9yrs | CN¥344.00k | no data | |
| Independent Non-executive Director | 1.9yrs | CN¥17.00k | no data | |
| Non-Executive Vice-Chairman | 1.9yrs | no data | 0.0016% CN¥ 142.0k | |
| Independent Non-Executive Director | 8.9yrs | CN¥344.00k | no data | |
| Non-Executive Director | 1.9yrs | no data | no data | |
| Non-Executive Director | 3yrs | no data | no data | |
| Independent Non-executive Director | 1.9yrs | CN¥17.00k | no data | |
| Non-Executive Director | 2.8yrs | no data | no data |
2.7yrs
Average Tenure
52yo
Average Age
Experienced Board: 2666's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.